These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32629416)

  • 1. Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.
    Terman SW; Aubert CE; Hill CE; Maust DT; Betjemann JP; Boyd CM; Burke JF
    Epilepsy Behav; 2020 Oct; 111():107261. PubMed ID: 32629416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.
    Terman SW; Niznik JD; Growdon ME; Gerlach LB; Burke JF
    Drugs Aging; 2023 Oct; 40(10):941-951. PubMed ID: 37695395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US.
    Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC
    JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and trend of central nervous system-active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study.
    Wei YJ; Shrestha N; Chiang C; DeKosky ST
    Alzheimers Res Ther; 2024 Feb; 16(1):30. PubMed ID: 38326897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and Other Central Nervous System-Active Polypharmacy in Older Adults in the United States.
    Gerlach LB; Olfson M; Kales HC; Maust DT
    J Am Geriatr Soc; 2017 Sep; 65(9):2052-2056. PubMed ID: 28467623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine and opioid co-usage in the US population, 1999-2014: an exploratory analysis.
    Vozoris NT
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30657987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy composition and patient- and provider-related variation in patients with epilepsy.
    Terman SW; Aubert CE; Maust DT; Hill CE; Lin CC; Burke JF
    Epilepsy Behav; 2022 Jan; 126():108428. PubMed ID: 34864378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Benzodiazepine Use With or Without Opioid Use and All-Cause Mortality in the United States, 1999-2015.
    Xu KY; Hartz SM; Borodovsky JT; Bierut LJ; Grucza RA
    JAMA Netw Open; 2020 Dec; 3(12):e2028557. PubMed ID: 33295972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy and chronic pain: harm exposure is not all about the opioids.
    Giummarra MJ; Gibson SJ; Allen AR; Pichler AS; Arnold CA
    Pain Med; 2015 Mar; 16(3):472-9. PubMed ID: 25280054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability in people with epilepsy: A nationally representative cross-sectional study.
    Terman SW; Hill CE; Burke JF
    Epilepsy Behav; 2020 Nov; 112():107429. PubMed ID: 32919202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Costs and Use of Older Americans in Assisted Living Settings: a Nationally Representative Cross-Sectional Study.
    Lei L; Samus QM; Thomas KS; Maust DT
    J Gen Intern Med; 2023 Feb; 38(2):294-301. PubMed ID: 35132546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in central nervous system-active polypharmacy among people with multiple sclerosis.
    Naizer H; Wozny J; Krause TM; Huson E; Freeman L
    Mult Scler; 2024 Aug; 30(9):1139-1150. PubMed ID: 38751229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study.
    Terman SW; Niznik JD; Slinger G; Otte WM; Braun KPJ; Aubert CE; Kerr WT; Boyd CM; Burke JF
    BMC Neurol; 2022 Sep; 22(1):328. PubMed ID: 36050646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National use of prescription medications for insomnia: NHANES 1999-2010.
    Bertisch SM; Herzig SJ; Winkelman JW; Buettner C
    Sleep; 2014 Feb; 37(2):343-9. PubMed ID: 24497662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016.
    Young EH; Pan S; Yap AG; Reveles KR; Bhakta K
    PLoS One; 2021; 16(8):e0255642. PubMed ID: 34343225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system-active medications and risk for falls in older women.
    Ensrud KE; Blackwell TL; Mangione CM; Bowman PJ; Whooley MA; Bauer DC; Schwartz AV; Hanlon JT; Nevitt MC;
    J Am Geriatr Soc; 2002 Oct; 50(10):1629-37. PubMed ID: 12366615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system (CNS) medications and polypharmacy in later life: cross-sectional analysis of the English Longitudinal Study of Ageing (ELSA).
    Slater N; White S; Frisher M
    BMJ Open; 2020 Sep; 10(9):e034346. PubMed ID: 32928845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
    Schabert VF; Stern S; Ferrari L; Wade CT; Willke RJ; Hauser WA
    Epilepsy Behav; 2022 Sep; 134():108865. PubMed ID: 35952507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications.
    Pugh MJ; Vancott AC; Steinman MA; Mortensen EM; Amuan ME; Wang CP; Knoefel JE; Berlowitz DR
    J Am Geriatr Soc; 2010 Mar; 58(3):465-71. PubMed ID: 20398114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy in nursing home residents in the United States: results of the 2004 National Nursing Home Survey.
    Dwyer LL; Han B; Woodwell DA; Rechtsteiner EA
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):63-72. PubMed ID: 20226393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.